Fresenius reported 9.17B in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akzo Nobel AKZA:NA 2.65B 355M
Alcon AG ALC:SW 1.93B 16.97M
AstraZeneca AZN:LN 840.42B 39.99B
BASF BAS:GR 20.62B 327M
Bayer BAYN:GR 12.65B 2.22B
Davita Healthcare Partners DVA:US $ 2494.04M 14.8M
E.ON EOAN:GR 28.24B 480M
Essilor EI:FP 10.28B 286M
Fresenius FRE:GR 9.17B 355M
Fresenius Medical Care FME:GR 4.42B 215.3M
Getinge GETIB:SS 5.76B 357M
Givaudan GIVN:VX 3.02B 186M
GlaxoSmithKline GSK:LN 584.8B 95.1B
GN Store Nord GN:DC 4.46B 495M
Hikma Pharmaceutical HIK:LN 79.18B 796.93M
Lonza Group LONN:SW 2.34B 4M
Merck MRK:GR 4.39B 366M
Novartis NOVN:VX 10.86B 895M
Philips PHIA:NA € 4166M 67M
RWE RWE:GR 8.96B 3.87B
William Demant Holding WDH:DC 7.91B 340M